Find company announcements below, or check out the latest news in the right side menu.
24. February 2012
In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
23. February 2012
21. February 2012
I henhold til Værdipapirhandelslovens paragraf 28a skal Novozymes offentliggøre følgende transaktioner under Fondskode (ISIN) DK0060336014, Novozymes B-aktier under betegnelsen NZYM B.
17. February 2012
On January 20, 2012, Novozymes initiated a share buyback program in accordance with the provisions of European Commission Regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbour Regulation.
16. February 2012
10. February 2012
3. February 2012
27. January 2012
26. January 2012
24. January 2012
20. January 2012
On January 20, 2012, Novozymes initiated a share buyback program in accordance with the provisions of European Commission (EC) Regulation No 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation.
19. January 2012
Growth in local currencies was 10% (8% DKK, 7% organic) compared to 2010. EBIT increased by 11% and took the EBIT margin to 22.3% despite a negative impact from higher raw material prices, acquisitions, and unfavorable currency rates.
21. December 2011
12. December 2011
1. December 2011
29. November 2011
22. November 2011
The trading unit of the Novozymes B stock will be changed from DKK 10 to DKK 2. The last day of trading in the old stock will be November 25, 2011, and the first day of trading in the new stock will be November 28, 2011.
11. November 2011
On February 11, 2011, Novozymes initiated a share buyback program in accordance with the provisions of European Commission Regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbour Regulation.
4. November 2011
28. October 2011
Satisfactory 9 months sales and earnings development with strong free cash flow. Full-year 2011 sales growth expected at ~ 8% in DKK, EBIT growth at 9−11%.
27. October 2011
Jury has found Danisco liable for infringing Novozymes’ US Patent No. 7,713,723 on alpha-amylases for use in the biofuel and starch industries.
21. October 2011
25. April 2013
1. April 2013
| Copyright © 2010 Novozymes. All Rights Reserved.